Shandong Weigao Medical Polymer (SHWGF) Stock Price, News & Analysis

Company Overview

Shandong Weigao Medical Polymer Co., Ltd. is a China-based developer, manufacturer and distributor of single-use polymer medical devices. The company’s product portfolio primarily includes infusion sets, blood transfusion sets, disposable syringes, catheter needles and a range of related accessories designed for use in hospitals, clinics and home healthcare settings. Leveraging advanced polymer processing technologies, Shandong Weigao serves both domestic and international markets with a focus on quality, safety and regulatory compliance.

Since its establishment in Weihai, Shandong Province, in the early 1990s, the company has built a vertically integrated manufacturing platform encompassing polymer resin compounding, injection molding, extrusion and final assembly. Over the years, Shandong Weigao has expanded its production network to multiple facilities in China, investing in automated cleanroom operations and in-house R&D centers. These investments have enabled the company to enhance product consistency and scale output to meet growing demand.

Shandong Weigao sells its products under its own brand while also providing original equipment manufacturing (OEM) and original design manufacturing (ODM) services to global medical device companies. Its export markets span more than 100 countries across Asia, Europe, the Americas and the Middle East. The company actively pursues international certifications, including CE marking and ISO 13485 accreditation, to facilitate cross-border sales and to comply with diverse regulatory requirements.

The company’s leadership team brings together expertise in polymer science, medical device engineering and healthcare regulation. Guided by a board of directors with decades of industry experience, Shandong Weigao continues to focus on innovation in material technologies, cost-effective production and expanded distribution channels. This strategic approach positions the company to address evolving needs in the global healthcare market, such as safer infusion products and next-generation minimally invasive therapy devices.

Key Stats

• Today's Range: $0.76 to $0.76
• 50-Day Range: $0.76 to $0.76
• 52-Week Range: $0.65 to $0.76
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: $3.46 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SHWGF Stock Analysis - Frequently Asked Questions

How have SHWGF shares performed this year?

Shandong Weigao Medical Polymer's stock was trading at $0.6655 at the beginning of 2025. Since then, SHWGF shares have increased by 14.9% and is now trading at $0.7649.

How do I buy shares of Shandong Weigao Medical Polymer?

Shares of SHWGF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/18/2025
• Next Earnings (Estimated): 8/26/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Personal Services
• Current Symbol: OTCMKTS:SHWGF
• CIK: 1505223
• Web: www.weigaogroup.com
• Phone: 0631-5621999
• Fax: 0631-5621999
• Employees: 12,519
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $1.82 billion
• Price / Sales: 1.90
• Cash Flow: $0.09 per share
• Price / Cash Flow: 8.18
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 4,522,330,000
• Free Float: N/A
• Market Cap: $3.46 billion
• Optionable: Not Optionable
• Beta: -0.23